September 23, 2022

    Cellular Goods launches Rejuvenating Skincare products containing PureForm CBD

    PureForm Global, Inc. (“PureForm Global”), a California-based biotechnology company focused on the research, development, and commercialisation of bioidentical lab-made cannabinoids, is pleased to announce that Cellular Goods (LSE: CBX), a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, has launched its first products formulated with PureForm CBD.

    PureForm Global’s proprietary, synthetically produced cannabidiol (“CBD”) has been used in the formulation of Cellular Goods’ new Rejuvenating Skincare products, released on 21 September 2022 as part of its ‘Look Better’ (skincare) range. The three products containing PureForm Global’s ultra-pure CBD include Cellular Goods’ Rejuvenating Night Cream, SPF 25 Rejuvenating Day Cream and Rejuvenating Day Mousse. The products contain PureForm CBD and focus on fighting the effects of inflammation, a root cause of skin ageing.

    PureForm Global develops and manufactures bioidentical cannabinoids for use in the consumer and pharmaceutical industries and produce CBD at commercial scale in facilities in the US and UK that are wholly FDA and Current Good Manufacturing Practice (cGMP) compliant. PureForm CBD has received certification from the Clean Label Project, an independent non-profit that is championing transparency in consumer product labelling. The Clean Label Project has awarded PureForm with its THC Free Award, Pesticide Free Certification and Purity award.

    Anna Chokina, Cellular Goods’ chief executive, said: “PureForm’s lab-based production method is faster, more efficient and has a greatly reduced carbon footprint compared to field-based production methods of CBD. Their UK manufacturing capabilities have the added benefit of a short supply chain, ensuring consistent supply of CBD in commercial quantities. We are delighted with the results of our partnership so far and look forward to a continuing relationship as we deliver high-quality products to our customers.”

    “Anna and her team make clear to their partners that the quality and purity of their products are non-negotiable. PureForm Global is proud to supply Cellular Goods with CBD for its wellness products, and we share their commitment to premium quality,” said Richard Nanula, PureForm’s CEO.

    March 8, 2022

    PureForm Global has been awarded its first Patent from the U.S. Patent and Trademark Office for its process for synthesizing CBD

    The patented process (U.S. Patent 11,267,774) uses as its primary starting material a compound derived from citrus terpenes. It is used to produce CBD that is bioidentical to the compound found in cannabis and hemp plants, except without the dangerous impurities found in those plant sources.
    "This patent represents an important proof of concept that PureForm intends to build upon in development of dozens of future cannabinoid compounds. We believe companies with valuable brands that want to bring the benefits of cannabinoids to their customers will only want consistent, pure, materials that are the same every time for their high-volume production lines,” said Damian Peters, co-founder of PureForm. “I would like to congratulate the co-inventors, Marc Bencivenga, Matthew Forster, Paul Herrington, Paul Jass, Surendra Singh, and Todd Zahn for their important work in helping PureForm achieve this first milestone of many.”

    December 7, 2021

    PureForm CBD achieves Clean Label Certification in three areas

    PureForm CBD has been certified by Clean Label Project, an independent product quality certification company. We have attained the Pesticide Free Certification, Purity Award and THC Free Award. There are only a few CBD brands that have passed these tests, and PureForm CBD is now the only CBD ingredient with these certifications.

    September 8, 2021

    Prohibition Partners: The Pharmaceutical Cannabis Report Edition 2

    The most common cannabinoids in cannabis plant material are THC and CBD or more specifically, their carboxylated form THCa and CBDa. These cannabinoid acids are transformed e.g. combustion provides the active THC and CBD which are associated with medicinal and recreational utility. However, there are a range of over 100 cannabinoid compounds which are variously referred to as ‘minor cannabinoids’, with biological activity, which have been established, but poorly investigated by researchers.

    Read More

    August 27, 2021

    August 9, 2021

    PureForm Global Secures European Food Safety Authority Novel Food Validation

    PureForm Global Inc, through its UK subsidiary PureForm International Ltd, has become the only UK CBD manufacturer to receive validation from the European Commission and the European Food Safety Authority for its Novel Food application.

    Read More

    March 17, 2021

    February 25, 2021

    September 2, 2020